Get the latest tech news
Platforma.bio by MiLaboratories is making waves in drug discovery
Contributor Content In the evolving field of bioinformatics, staying current is a challenge. For MiLaboratories, the challenge was creating software called Platforma.bio, which not only simplifies the complex analysis of immunogenomic data for researchers, but furthers the technology critical for drug discovery, especially in the field of mRNA vaccines and oncovaccines. The recent launch of Platforma software […]
For MiLaboratories, the challenge was creating software called Platforma.bio, which not only simplifies the complex analysis of immunogenomic data for researchers, but furthers the technology critical for drug discovery, especially in the field of mRNA vaccines and oncovaccines. The recent launch of Platforma software is accompanied by the April announcement of partnerships with Miltenyi Biotech, whose robust production and commercialization capabilities will fast-track the adoption of full cycle next generation therapies for patients. Aiming to become leading names in the field of immunogenic analysis and personalized medicine, MiLaboratories and their previouse software MiXCR could eventually represent not just tools, but a new generation of precise, data-driven, and patient-centric care.
Or read this on Venture Beat
